201 related articles for article (PubMed ID: 1735693)
1. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
[TBL] [Abstract][Full Text] [Related]
2. DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation.
Buchko GW; Weinfeld M
Radiat Res; 2002 Sep; 158(3):302-10. PubMed ID: 12175307
[TBL] [Abstract][Full Text] [Related]
3. Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines.
Cowan DS; Panicucci R; McClelland RA; Rauth AM
Radiat Res; 1991 Jul; 127(1):81-9. PubMed ID: 2068275
[TBL] [Abstract][Full Text] [Related]
4. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin.
Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities.
Cowan DS; Matejovic JF; Wardman P; McClelland RA; Rauth AM
Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a cell line resistant to 5-[3-(2-nitro-1-imidazoyl)-propyl]-phenanthridinium bromide (2-NLP-3), a DNA-intercalating hypoxic cell radiosensitizer and cytotoxin.
Cowan DS; McClelland RA; Rauth AM
Biochem Pharmacol; 1995 Jun; 50(1):61-8. PubMed ID: 7605346
[TBL] [Abstract][Full Text] [Related]
7. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
[TBL] [Abstract][Full Text] [Related]
8. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR
Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695
[TBL] [Abstract][Full Text] [Related]
9. DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies.
Cowan DS; Matejovic JF; McClelland RA; Rauth AM
Br J Cancer; 1994 Dec; 70(6):1067-74. PubMed ID: 7981056
[TBL] [Abstract][Full Text] [Related]
10. 4-Fluorobenzylamine and phenylalanine methyl ester conjugates of 2-nitroimidazole: evaluation as hypoxic cell radiosensitizers.
Garg PK; Garg S; Degraff WG; Zalutsky MR; Mitchell JB
Int J Radiat Oncol Biol Phys; 1992; 22(3):593-6. PubMed ID: 1531220
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
Ahmed I; Stratford IJ; Jenkins TC
Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
[TBL] [Abstract][Full Text] [Related]
13. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-selective radiosensitization of mammalian cells by nitracrine, an electron-affinic DNA intercalator.
Roberts PB; Anderson RF; Wilson WR
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Apr; 51(4):641-54. PubMed ID: 3495509
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD
Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276
[TBL] [Abstract][Full Text] [Related]
16. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents.
Jenkins TC; Stratford IJ; Stephens MA
Anticancer Drug Des; 1989 Aug; 4(2):145-60. PubMed ID: 2803463
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
Papadopoulou MV; Rosenzweig HS; Bloomer WD
Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA
J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the radiosensitization potency afforded by nitroacridine intercalators with their electron scavenging efficiency in DNA.
Anderson RF; Denny WA; Roberts PB; Wardman P; White J; Wilson WR
Int J Radiat Oncol Biol Phys; 1992; 22(3):537-40. PubMed ID: 1735692
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides.
Bonnet M; Hong CR; Wong WW; Liew LP; Shome A; Wang J; Gu Y; Stevenson RJ; Qi W; Anderson RF; Pruijn FB; Wilson WR; Jamieson SMF; Hicks KO; Hay MP
J Med Chem; 2018 Feb; 61(3):1241-1254. PubMed ID: 29253343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
